The Fletcher-Cox Pathway: A Unique View on Clinical Trial Education.

Autor: Moningi S; Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Stecklein S; Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, Kansan., Noticewala S; Department of Radiation Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas., Gjyshi O; Department of Radiation Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas., Pezzi T; Department of Radiation Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas., Boyce-Fappiano D; Department of Radiation Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas., Das P; Department of Radiation Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas., Minsky B; Department of Radiation Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas., Holliday EB; Department of Radiation Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas., Bishop AJ; Department of Radiation Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas., Koong AC; Department of Radiation Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas., Pinnix CC; Department of Radiation Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas.

Publikováno v: Advances in radiation oncology [Adv Radiat Oncol] 2024 Sep 14; Vol. 9 (12), pp. 101637. Date of Electronic Publication: 2024 Sep 14 (Print Publication: 2024).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Circulating neutrophils and tumor-associated myeloid cells function as a powerful biomarker for response to chemoradiation in locally advanced cervical cancer.

Autor: Gjyshi O; Department of Radiation Oncology, Saint Elizabeth Cancer Center, Edgewood, KY, United States., Grippin A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., Andring L; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., Jhingran A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., Lin LL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., Bronk J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., Eifel PJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., Joyner MM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., Sastry JK; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Yoshida-Court K; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., Solley TN; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Napravnik TC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., O'Hara MP; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hegde VL; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Colbert LE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States., Klopp AH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Medicine, United States.

Publikováno v: Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2023 Jan 11; Vol. 39, pp. 100578. Date of Electronic Publication: 2023 Jan 11 (Print Publication: 2023).

Payment Methodology for the Radiation Oncology Alternative Payment Model: Implications for Practices and Suggestions for Improvement.

Autor: Boyce-Fappiano D; The University of Texas MD Anderson Cancer Center, Houston, TX., Ning MS; The University of Texas MD Anderson Cancer Center, Houston, TX., Gjyshi O; The University of Texas MD Anderson Cancer Center, Houston, TX., Mesko S; The University of Texas MD Anderson Cancer Center, Houston, TX., Pasalic D; The University of Texas MD Anderson Cancer Center, Houston, TX., Chang AJ; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA., Orio PF 3rd; Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA., Thaker NG; Arizona Oncology, Tucson, AZ.

Publikováno v: JCO oncology practice [JCO Oncol Pract] 2021 Dec; Vol. 17 (12), pp. 761-764. Date of Electronic Publication: 2021 Jun 07.

Dynamic Tumor Mutational Profiling Using a Novel Non-Invasive Swab Technique for Serial Whole Exome Sequencing of Cervical Tumors During Chemoradiation Therapy

Autor: Bronk, J.K., Wu, X., Chapman, B.V., Karpinets, T., Sims, T., Gjyshi, O., Eifel, P.J., Jhingran, A., Lin, L.L., Ramondetta, L., Futreal, P.A., Schmeler, K., Yue, J., Court, K., Solley, T., Ahmad-Kaddar, M., Lynn, E.J., Zhang, J., Klopp, A.H., Colbert, L.

Publikováno v: In International Journal of Radiation Oncology, Biology, Physics 1 November 2021 111(3) Supplement:S136-S137